Identifying Peptide-Peptide Interactions with Lysenin Nanopores

Abstract

Numerous peptides have been identified as biomarkers, providing valuable information about diseases such as cancer, heart disease, rheumatoid arthritis, Alzheimer's, and kidney disease. Similarly, the analysis of peptides has emerged as a powerful tool for various diagnostic, therapeutic, and biomedical applications. In this context, there is a tremendous need for investigating and characterizing peptides beyond the established methods such as mass spectrometry, fluorescence spectroscopy, and immune staining.